Skip to content

Clinical trials

Phase 1 Marijuana Abuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Marijuana Abuse Phase: Phase 1 Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20064
20073
20086
20093
20101
20112
20123
20131
20146
20155
20169
20177
20185
20197
20206
202111
20229
20236
20246
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Recruiting15
Active, not recruiting10
Unknown status10
Terminated8
Not yet recruiting8
Withdrawn5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University26
Johns Hopkins University16
National Institute on Drug Abuse (NIDA)7
University of California, Los Angeles7
Jazz Pharmaceuticals5
New York State Psychiatric Institute4
Shanna Babalonis, PhD4
Aelis Farma3
Battelle Memorial Institute3
University of California, San Diego3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Marijuana Abuse123
Psychotic Disorders11
Pain10
Substance-Related Disorders10
Mental Disorders3
Opioid-Related Disorders3
Cognitive Dysfunction2
Marijuana Use2
Schizophrenia2
Tobacco Use Disorder2

Trials

Showing 51 to 75 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.